During the past decade, Main Line Health NCORP conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 28 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 12 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Main Line Health NCORP" #1 collaborator was "National Cancer Institute (NCI)" with 11 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Main Line Health NCORP" are "Recurrent Ovarian Carcinoma" (4 trials), "Recurrent Fallopian Tube Carcinoma" (3 trials), "Recurrent Primary Peritoneal Carcinoma" (3 trials), "Recurrent Uterine Corpus Carcinoma" (3 trials) and "Stage IIA Fallopian Tube Cancer AJCC v6 and v7" (3 trials). Many other conditions were trialed in "Main Line Health NCORP" in a lesser frequency.

Most popular intervention types in "Main Line Health NCORP" are "Other" (31 trials), "Drug" (28 trials), "Biological" (18 trials), "Radiation" (8 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (23 trials), "Quality-of-Life Assessment" (15 trials), "Paclitaxel" (11 trials), "Bevacizumab" (9 trials) and "Questionnaire Administration" (8 trials). Other intervention names were less common.

The vast majority of trials in "Main Line Health NCORP" are 21 trials for "All" genders and 17 trials for "Female" genders.

Currently, there are NaN active trials in "Main Line Health NCORP". undefined are not yet recruiting, undefined are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Main Line Health NCORP, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Main Line Health NCORP, 3 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".